| 000 | 01455nam a2200385 c 4500 | ||
|---|---|---|---|
| 008 | 190328t2019 xxka 000 0 eng d | ||
| 020 |
_a9780128140390 _cRM569.94 |
||
| 020 |
_a9780128140390 _cRM583.74 (PRAKLINIKAL) |
||
| 040 |
_aUKM _erda |
||
| 090 |
_aQZ266 _b.R467v 2019 9HUKM |
||
| 090 |
_aQZ266 _b.R467v 2019 9HUKMPRA |
||
| 100 | 1 |
_aRezaei, Nima, _eauthor. |
|
| 245 | 1 | 0 |
_aVaccines for cancer immunotherapy : _ban evidence-based review on current status and future perspectives / _cNima Rezaei, Mahsa Keshavarz-Fathi. |
| 264 | 4 |
_aLondon, United Kingdom : _bAcademic Press, _c[2019]. |
|
| 264 | 4 | _c©2019. | |
| 300 |
_axiii, 183 pages : _billustrations _c24 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 2 |
_aNeoplasms _xtherapy. |
|
| 650 | 2 |
_aNeoplasms _ximmunology. |
|
| 650 | 2 |
_aImmunotherapy _xmethods. |
|
| 650 | 2 |
_aCancer Vaccines _xtherapeutic use. |
|
| 650 | 2 | _aEvidence-Based Medicine. | |
| 700 | 1 |
_aKeshavarz-Fathi, Mahsa, _eauthor. |
|
| 907 |
_a.b16705749 _b2024-10-17 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQZ266 .R467v 2019 9HUKM |
||
| 914 | _avtls003646025 | ||
| 949 | _o100979789 (Pra) | ||
| 990 | _aSalmah/azriq/intan | ||
| 991 | _aJabatan Onkologi, PPUKM | ||
| 991 | _aJabatan Mikrobiologi dan Imunologi, Praklinikal | ||
| 998 |
_ap _ah _b2019-02-03 _cm _da _feng _gxxk _y0 _z.b16705749 |
||
| 999 |
_c638596 _d638596 |
||